Exploring China: Legal, Regulatory and Cultural Aspects

International Regulatory Science Symposium
Exploring China: Legal, Regulatory and Cultural Aspects
 
Don’t miss this unique opportunity to hear from the leaders in China Biomedical industry!
 
China poses both enormous economic potential and uncertain business risk for the biomedical industry that would like to tap into its expanding economy, aging population and growing talent pool.  Its rapid rise in GDP, establishment of social infrastructure, and efforts to incentivize domestic R&D continue to attract companies to invest in the market and explore opportunities amidst rapidly changing environment.
 
This one-day symposium will feature speakers from industry, academia, and government to present current developments, issues, and challenges facing the biomedical industry in China.
 
Agenda Highlights:
China’s Role in Biomedical Industry: Past, Present, and Future 
Medical Device Regulation 
Health System and Policy
Medical Insurance Systems in China 
Medical Device Evaluation
Innovation and Start-ups 
Practical Aspects of Chinese Law 
Intellectual Property Considerations
 
Featured speakers include:
Dan Harris, JD, Harris Moure, Seattle, Washington
Helen Niu, MD, PhD, Head, Senior Director, China Clinical Development of Allergan, Beijing, China
Annie Yin, DBA, Regulatory Affairs Director, Medtronic Inc., Beijing, China
Click here for speakers’ bios
 
Who should attend:
Biomedical and Medtech industry professionals and executives
Faculty, students, and staff interested in learning about this exciting field
 
We look forward to welcoming you on November 1st!
Advertisements

Comments are closed.

%d bloggers like this: